Drug Database
Back to search

Poland· PL-100102565

Meteospasmyl

A alverin, kombinationen product containing alverini citras + simeticonum, registered in Poland by LABORATOIRES MAYOLY SPINDLER. The same ATC class is registered in 4 of our 19 countries.

ATC A03AX58

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMeteospasmylATCA03AX58REGISTER NO.PL-100102565PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alverini citras + simeticonumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Alverin, kombinationen is registered in 4 of 19 countries.

Countries holding a registration under ATC A03AX58 (alverin, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose
Search alverin, kombinationen products by name

Alverin, kombinationen · ATC A03AX58

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Alverini citras + Simeticonum
Manufacturer
LABORATOIRES MAYOLY SPINDLER
Country
Poland (PL)
ATC code
A03AX58
ATC class
Alverin, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990883219
  • gtin
    05909990970346
  • gtin
    05909991268213
  • gtin
    05909991426415

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A03AX58

Alverin, kombinationen, as other registers publish it.

All alverin, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7170fed8-5e0d-4fb9-b91d-e28200e49229
GET /v1/drugs/7170fed8-5e0d-4fb9-b91d-e28200e49229?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki",
  "source": "urpl",
  "strength": "60 mg + 300 mg",
  "packaging": "05909990883219 ¦ Rp ¦ 17715\n20 kaps.\n05909990970346 ¦ Rp ¦ 76078\n30 kaps.\n05909991268213 ¦ Rp ¦ 114847\n40 kaps.\n05909991426415 ¦ Rp ¦ 135711\n64 kaps.",
  "substance": "Alverini citras 60 mg + Simeticonum 300 mg",
  "common_name": "Alverini citras + Simeticonum",
  "pl_product_id": "100102565",
  "pozwolenie_nr": "08832",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about alverin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console